Administration of anti-CD25 antibody decreases the early and late organ fungal burdens of resistant and susceptible mice. by Maíra Felonato (296591)

Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography by O. Stivalet (6890189)

“…In the subset of patients with an ABI >0.91, cut-off values of post-exercise ABI decrease (AUC = 0.67[0.53–0.78]), and DROP (AUC = 0.67[0.53–0.78]) were ≥18.5%, and ≤-15mmHg respectively (p<0.05).…”

Annual soil respiration (R) and its % decreased for each year in the pine forest (PF), the mixed conifer and broadleaf forest (MF) and the broadleaved forest (BF) under different S... by Guohua Liang (406160)

“…The treatments are: CK = control, T1 = pH 4.0, T2 = pH 3.5, T3 = pH 3.0. % decreased = 100 ((R of the CK treatment – R of each treatment)/R of the CK treatment) % (in the same time period); negative values within the column means % increased. …”

Change of oxygen concentration at each measuring point. by Yun Qi (560401)

Change of the switch point between dual-E and single-E control with decreasing values of <i>k</i>₉, <i>k</i>₁₁, and <i>k</i>₁₃. by Qaiser Waheed (5095328)

Klf5 activates the transcription of the eIF5a gene through direct binding to its promoter. by Dong Ma (584680)

Subjects:

Phlorizin decreased renal GTTR uptake, and increased serum drug levels <i>in vivo</i>. by Meiyan Jiang (438439)

Results of comparison between Model5 and Model9. by Taiga Mori (21410076)

Results of comparison between Model5 and Model10. by Taiga Mori (21410076)

Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Serotype-specific penicillin non-susceptibility during different PCV periods in Iceland, Romania, Spain and Belgium [68, 69, 76, 78, 84, 85]. by Heloisa Ricci Conesa (18291210)

Subjects:

Procedures of sampling and measurements. by Xuegang Mao (599968)

Subjects:

Introduction status of PCVs in European countries over time. by Heloisa Ricci Conesa (18291210)

Subjects:

Data extraction grid. by Heloisa Ricci Conesa (18291210)

Subjects:

Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

Subjects:

Inclusion criteria. by Heloisa Ricci Conesa (18291210)

Subjects:

PRISMA flow diagram for the literature search. by Heloisa Ricci Conesa (18291210)

Subjects:

Estimates for direct medical and total costs per AOM episode (2020 EUR), by country [35, 96–100]. by Heloisa Ricci Conesa (18291210)

Subjects:

Vertical distributions in the three field settings. by Xuegang Mao (599968)

Subjects: